ArticleCancer cell international2021

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis.

Tingting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.